Prevention and treatment of infections in cystic fibrosis.

Prevention and treatment of infections in cystic fibrosis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Prevention and treatment of infections in cystic fibrosis. Abstract Text:

Prevention and treatment of infections in cystic fibrosis. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Prevention and treatment of infections in cystic fibrosis. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: International journal of antimicrobial agents

VOLUME: 1

Page Numbers: 229-37

Journal Abbreviation: Int. J. Antimicrob. Agents

ISSN: 0924-8579

DAY: 9

MONTH: Sep

YEAR: 1992

Prevention and treatment of infections in cystic fibrosis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9111860

Prevention and treatment of infections in cystic fibrosis. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Prevention and treatment of infections in cystic fibrosis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Prevention and treatment of infections in cystic fibrosis.

AFFILIATION: Department of Clinical Microbiology, Righospitalet, University of Copenhagen, Copenhagen, Denmark.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Int J Antimicrob Agents

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Prevention and treatment of infections in cystic fibrosis Related Publications

• Activated complement in the sputum from patients with cystic fibrosis.
• Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice.
• Changes in serotype caused by cell to cell contact between different Pseudomonas aeruginosa strains from cystic fibrosis patients.
• Class A carbapenemases.
• Crossed immunoelectrophoretic analysis of Flavobacterium meningosepticum and allied Flavobacterium taxa.
• Crossed immunoelectrophoretic analysis of Neisseria meningitidis antigens and of corresponding antibodies in patients with meningococcal disease.
• Effect of Pseudomonas aeruginosa proteases on human leukocyte phagocytosis and bactericidal activity.
• Effect of aerobic and anaerobic atmosphere on the detection of micro-organisms from blood cultures.
• Effect of antimalarial drugs on human neutrophil chemotaxis in vitro.
• Immunoglobulins and albumin in sputum from patients with cystic fibrosis. A study of protein stability and presence of proteases.
• Polyagglutinability due to loss of O-antigenic determinants in Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
• Precipitating antibodies against Neisseria meningitidis in normal sera and their possible origin.
• Prevention and treatment of infections in cystic fibrosis.
• Pseudomonas aeruginosa diversity in distinct paediatric patient groups.
• Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa.
• [A good reason to be on guard]
• [Blood cultures in general practice. Suspected meningococcal disease and other serious infections with bacteremia]
• [In Process Citation]
• [New recommendations for antibiotic dosing in patients with renal insufficiency and in patients undergoing haemodialysis]